Agnitio Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGNITIO, and what generic and branded alternatives to AGNITIO drugs are available?
AGNITIO has four approved drugs.
Drugs and US Patents for Agnitio
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agnitio | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211809-001 | Jul 12, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agnitio | TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agnitio | PHYTONADIONE | phytonadione | TABLET;ORAL | 213336-001 | Oct 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agnitio | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214969-001 | Sep 2, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agnitio | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214969-002 | Sep 2, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agnitio | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214969-004 | Sep 2, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.